SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.

SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.